Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study

L. Akulkina (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), N. Bulanov (Moscow, Russian Federation), P. Novikov (Moscow, Russian Federation), A. Zykova (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), A. Moiseev (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), A. Kitbalian (Moscow, Russian Federation), N. Chichkova (Moscow, Russian Federation), V. Fomin (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), N. Trushenko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation)

Source: Virtual Congress 2021 – Acute COVID - 19
Session: Acute COVID - 19
Session type: Oral Presentation
Number: 3970

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Akulkina (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), N. Bulanov (Moscow, Russian Federation), P. Novikov (Moscow, Russian Federation), A. Zykova (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), A. Moiseev (Moscow, Russian Federation), A. Schepalina (Moscow, Russian Federation), A. Kitbalian (Moscow, Russian Federation), N. Chichkova (Moscow, Russian Federation), V. Fomin (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), N. Trushenko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation). Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study. 3970

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020
Year: 2020



Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021


Adequacy of treatment in COPD patients referred to the emergency room for disease exacerbation: an Italian multicentre observational study (the COXER study)
Source: Annual Congress 2008 - Management of COPD
Year: 2008


PFBIO EXA: A prospective cohort of respiratory hospitalization in IPF patients.
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Survival after intensive care for COPD exacerbation in patients with and without long-term oxygen therapy: a nationwide cohort study
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019

Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study
Source: ERJ Open Res, 6 (3) 00126-2020; 10.1183/23120541.00126-2020
Year: 2020



Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


PICU admission in children with severe acute asthma: a multicenter prospective study
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019


Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020



Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



Health care costs in COPD patients with severe respiratory failure: a prospective analysis
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Tele-assistance in chronic respiratory failure patients: a randomised clinical trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020
Year: 2021



Diagnosing asthma and COPD in primary care patients in Serbia: A multicenter study
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012


Home care combining oral nutritional supplement, exercise and androgen substitution in malnourished patients with chronic respiratory failure: a prospective controlled randomized multicenter trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008

Procalcitonin-guided assessment of bacterial etiological role in patients admitted for severe COPD exacerbations: a double-blind study
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Effects of eight week combined home and outpatient pulmonary rehabilitation in patients with COPD: A Korean multicenter observational study
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017

Procalcitonin as a predictor of pneumonia in patients hospitalized with acute exacerbation of COPD: a prospective observational study
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Short-term effects of respiratory physiotherapy in infants with bronchiolitis and outpatient care: A multicentre study
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

A multicenter randomised controlled trial to evaluate continuous-positive airway pressure (CPAP) versus conventional oxygen in patients with acute respiratory failure (ARF) due to community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009